NEW PRAGUE, Minn. / Jun 06, 2023 / Business Wire / Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the virtual Sidoti Summer Small Cap Conference on June 14-15, 2023.
Electromed’s management team will present at 12:15 p.m. Eastern Time on Wednesday, June 14, 2023. A live and archived webcast of the event will be available on the Electromed website under Events & Presentations. You can also access the live webcast directly, here.
About Electromed, Inc.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
| Last Trade: | US$21.96 |
| Daily Change: | -0.04 -0.18 |
| Daily Volume: | 65,543 |
| Market Cap: | US$185.740M |
April 03, 2025 November 12, 2024 | |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
